ep 39: expansion of the immature b lymphocyte compartment in graves' disease
Published 9 months ago • 99 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
46:14
efl044 - long-term medical treatment of graves disease
-
39:19
immunology fall 2019 lecture 12: b cell selection
-
0:50
phase i study of tak-676 pembrolizumab following radiotherapy in late-line nsclc, tnbc and scchn
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
14:34
enp68: hypercalcemia of malignancy
-
1:07
phase ii results for pembrolizumab monotherapy in metastatic tnbc
-
3:31
osimertinib changed the treatment paradigm for repeat molecular testing at progression?
-
1:43
beyond the barrier: the immune-inspired pathways of tumor extravasation
-
5:37
phase iii trial shows pembrolizumab preferable to ipilimumab in advanced melanoma
-
1:08
a study investigating pembrolizumab in combination with eribulin in tnbc
-
2:15
cd8 t cell expansion in cll patients treated with ibrutinib
-
4:12
eribulin in recurrent metastatic er breast cancer
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
6:24
immunology (neutrophil) lecture 3 part 6
-
4:38
ash 2014: phase ii study of lenalidomide plus rituximab for mantle cell lymphoma (part 1)
-
5:45
case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
-
3:15
immunology (neutrophil) lecture 3 part 12
-
7:02
buparlisib helps overcome endocrine resistance in metastatic breast cancer: belle-2 trial results